| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: group of inventions concerns medicine, namely to ophthalmology, and concerns use of combretastatin and its phosphatic promedicine for treatment or prevention of a pathological myopia. n EFFECT: improvement of visual acuity at the patient, suffering a pathological myopia, reduction of the exudative phenomena, induction regresses of proliferation of vessels, suppression of growth of a proliferating vascular tree. n 40 cl, 5 dwg, 12 tbl, 10 ex |